146 related articles for article (PubMed ID: 8058045)
1. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
Christopoulos A; Mitchelson F
Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
[TBL] [Abstract][Full Text] [Related]
2. Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.
Christopoulos A; Loiacono R; Mitchelson F
Eur J Pharmacol; 1993 Jun; 246(1):1-8. PubMed ID: 8354340
[TBL] [Abstract][Full Text] [Related]
3. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
[TBL] [Abstract][Full Text] [Related]
4. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
Tränkle C; Andresen I; Lambrecht G; Mohr K
Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
[TBL] [Abstract][Full Text] [Related]
5. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
Eur J Pharmacol; 1996 Nov; 316(1):27-32. PubMed ID: 8982646
[TBL] [Abstract][Full Text] [Related]
6. Use of a spreadsheet to quantitate the equilibrium binding of an allosteric modulator.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1998 Aug; 355(1):103-11. PubMed ID: 9754944
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors.
Christopoulos A; Sorman JL; Mitchelson F; El-Fakahany EE
Biochem Pharmacol; 1999 Jan; 57(2):171-9. PubMed ID: 9890565
[TBL] [Abstract][Full Text] [Related]
8. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptors.
Lanzafame A; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):830-7. PubMed ID: 14617684
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl ammonium bromide).
Choo LK; Mitchelson F
Eur J Pharmacol; 1989 Mar; 162(3):429-35. PubMed ID: 2744077
[TBL] [Abstract][Full Text] [Related]
11. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
12. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
Lanzafame AA; Sexton PM; Christopoulos A
Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV
Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
[TBL] [Abstract][Full Text] [Related]
14. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
Choo LK; Mitchelson F
Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):601-11. PubMed ID: 1703935
[TBL] [Abstract][Full Text] [Related]
16. Variation in the affinity of amitriptyline for muscarine receptor subtypes.
Choi A; Mitchelson F
Pharmacology; 1994 May; 48(5):293-300. PubMed ID: 8016190
[TBL] [Abstract][Full Text] [Related]
17. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
18. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
Lanzafame A; Christopoulos A; Mitchelson F
Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the muscarine receptor subtype on sympathetic nerve endings in the rat caudal artery.
Shen A; Mitchelson F
Eur J Pharmacol; 1994 Feb; 252(2):167-72. PubMed ID: 7512503
[TBL] [Abstract][Full Text] [Related]
20. Binding profiles of class I antiarrhythmic agents to cardiac muscarinic receptors: competitive and allosteric interactions with the receptors and their pharmacological significance.
Endou M; Gando S; Hattori Y; Kanno M
J Pharmacol Exp Ther; 1991 Sep; 258(3):992-8. PubMed ID: 1890628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
